+91 954 002 5025 (24/7)
Dr. Ajay Sharma
Senior Director & Unit Head - Medical Oncology
Cancer Centre, Thorax & Lung Cancer Programme, Head and Neck Cancer Programme, Thoracic Cancer Programme, Breast Cancer Programme, Thyroid Cancer Programme, Advance Urology Cancer Programme, Gastrointestinal (GI) Cancer Programme, Sarcoma and Bone Cancer Programme, Lymphoma Cancer Programme, Paediatric Cancer Programme, Gynaecologic Cancer Programme, Medical Oncology
BLK-Max Super Speciality Hospital, Delhi
Experience: 15+ Years
Share Doctor Profile
Select Hospital
About Dr. Ajay Sharma
Dr. Ajay Sharma is a leading name when it comes to speciality in Medical Oncology treatment in India. He has been widely acknowledge for his versatile and patient-centric approach.
WORK EXPERIENCE
-
Currently working at BLK-Max Super Speciality Hospital, New Delhi (Mar 2026 - Present)
-
Unit Head and Senior Consultant – Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi (Aug 2022 - Sep 2023)
-
Principal Consultant – Medical Oncology, Max Super Speciality Hospital, Shalimar Bagh, New Delhi (Dec 2020 - Aug 2022)
-
Unit Head – Medical Oncology, Action Cancer Hospital, Paschim Vihar, New Delhi (Dec 2016 - Nov 2020)
-
Consultant – Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi (Oct 2014 - Nov 2016)
-
Consultant – Medical Oncology, Action Cancer Hospital, Paschim Vihar, New Delhi (Jun 2011 - Oct 2014)
-
Associate Consultant – Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi (Aug 2010 - Jun 2011)
EDUCATION & TRAINING
-
ECMO European Certification (Medical Oncology) – Amsterdam (2013)
-
DNB (Medical Oncology) – Rajiv Gandhi Cancer Institute and Research Centre, New Delhi (2011)
-
MD (General Medicine) – Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu & Kashmir (2006)
-
MBBS – Government Medical College, Jammu & Kashmir (2001)
MEMBERSHIPS
-
American Society of Clinical Oncology (ASCO)
-
European Society for Medical Oncology (ESMO)
-
Indian Society of Medical and Paediatric Oncology (ISMPO)
-
Indian Medical Association (IMA)
-
Dubai Health Authority (DHA)
RESEARCH PAPERS & PUBLICATIONS
-
Paper Presentation, “Eribulin Mesylate in Advanced Breast Cancer”, ESMO Asia Congress, Singapore (2016)
-
Research Paper, “Dasatinib in CML Patients”, Annals of Oncology (2009)
-
Research Paper, “Lenalidomide in CLL After FCR Failure”, Indian Journal of Haematology & Blood Transfusion, ISHTM Conference, AIIMS (2009)
-
Research Paper, “Altretamine in Advanced Ovarian Carcinoma”, Annals of Oncology (2008)
OPD Timings
